Determination of temozolomide in serum and brain tumor with micellar electrokinetic capillary chromatography

Melinda Andrási, Brigitta Törzsök, Álmos Klekner, Attila Gáspár

Research output: Contribution to journalArticle

14 Citations (Scopus)


Micellar electrokinetic capillary chromatographic (MEKC) with photodiode-array detection was applied to determine temozolomide (TMZ) in human serum and brain tumor. The limit of quantitation (LOQ) was 0.096μg/mL using 325nm as detection wavelength. The method made possible that the TMZ could be detected in in vivo serum samples without sample pretreatment. In order to detect TMZ at lower concentration, an extraction with ethyl acetate was applied to preconcentrate the analyte. Small amount of brain tumor tissues (less than 1g) were lyophilized and pretreated using extraction as a clean up and concentrating step. After removing the organic solvent a final sample volume of only 10μL was analyzed. The obtained peak concentrations (8.2-10.1μg/mL) and T max (44-65min) of TMZ in serum were similar to the data reported by others, the in vivo TMZ concentrations found in brain tumor ranged between 0.061 and 0.117μg/g.

Original languageEnglish
Pages (from-to)2229-2233
Number of pages5
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Issue number23
Publication statusPublished - Aug 1 2011



  • Brain
  • MEKC
  • Serum
  • Temozolomide
  • Tumor

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Clinical Biochemistry
  • Cell Biology

Cite this